5vet

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (04:52, 21 November 2024) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 5vet is ON HOLD
+
==PHOSPHOLIPASE A2, RE-REFINEMENT OF THE PDB STRUCTURE 1JQ8 WITHOUT THE PUTATIVE COMPLEXED OLIGOPEPTIDE==
 +
<StructureSection load='5vet' size='340' side='right'caption='[[5vet]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[5vet]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Daboia_russelii_pulchella Daboia russelii pulchella]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5VET OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5VET FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2&#8491;</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5vet FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5vet OCA], [https://pdbe.org/5vet PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5vet RCSB], [https://www.ebi.ac.uk/pdbsum/5vet PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5vet ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/PA2B8_DABRR PA2B8_DABRR] Snake venom phospholipase A2 (PLA2) that shows weak neurotoxicity and medium anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (IC(50) is 130 nM) (PubMed:18062812). It also damages vital organs such as lung, liver and kidney, displays edema-inducing activities when injected into the foot pads of mice and induces necrosis of muscle cells when injected into the thigh muscle. Has a low enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.<ref>PMID:18062812</ref> <ref>PMID:2115497</ref> <ref>PMID:8835338</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
The massive technical and computational progress of biomolecular crystallography has generated some adverse side effects. Most crystal structure models, produced by crystallographers or well-trained structural biologists, constitute useful sources of information, but occasional extreme outliers remind us that the process of structure determination is not fail-safe. The occurrence of severe errors or gross misinterpretations raises fundamental questions: Why do such aberrations emerge in the first place? How did they evade the sophisticated validation procedures which often produce clear and dire warnings, and why were severe errors not noticed by the depositors themselves, their supervisors, referees, and editors? Once detected, what can be done to either correct, improve, or eliminate such models? How do incorrect models affect the underlying claims or biomedical hypotheses they were intended, but failed, to support? What is the long-range effect of the propagation of such errors? And finally, what mechanisms can be envisioned to restore the validity of the scientific record and, if necessary, retract publications that are clearly invalidated by the lack of experimental evidence? We suggest that cognitive bias and flawed epistemology are likely at the root of the problem. By using examples from the published literature and from public repositories such as the Protein Data Bank, we provide case summaries to guide correction or improvement of structural models. When strong claims are unsustainable because of a deficient crystallographic model, removal of such a model and even retraction of the affected publication are necessary to restore the integrity of the scientific record. This article is protected by copyright. All rights reserved.
-
Authors: Wlodawer, A., Dauter, Z., Minor, W., Stanfield, R., Porebski, P., Jaskolski, M., Pozharski, E., Weichenberger, C.X., Rupp, B.
+
Detect, Correct, Retract: How to manage incorrect structural models.,Wlodawer A, Dauter Z, Porebski PJ, Minor W, Stanfield R, Jaskolski M, Pozharski E, Weichenberger CX, Rupp B FEBS J. 2017 Nov 7. doi: 10.1111/febs.14320. PMID:29113027<ref>PMID:29113027</ref>
-
Description: PHOSPHOLIPASE A2, RE-REFINEMENT OF THE PDB STRUCTURE 1JQ8 WITHOUT THE PUTATIVE COMPLEXED OLIGOPEPTIDE
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
-
[[Category: Dauter, Z]]
+
<div class="pdbe-citations 5vet" style="background-color:#fffaf0;"></div>
-
[[Category: Rupp, B]]
+
 
-
[[Category: Porebski, P]]
+
==See Also==
-
[[Category: Weichenberger, C.X]]
+
*[[Phospholipase A2 3D structures|Phospholipase A2 3D structures]]
-
[[Category: Pozharski, E]]
+
== References ==
-
[[Category: Wlodawer, A]]
+
<references/>
-
[[Category: Minor, W]]
+
__TOC__
-
[[Category: Jaskolski, M]]
+
</StructureSection>
-
[[Category: Stanfield, R]]
+
[[Category: Daboia russelii pulchella]]
 +
[[Category: Large Structures]]
 +
[[Category: Dauter Z]]
 +
[[Category: Jaskolski M]]
 +
[[Category: Minor W]]
 +
[[Category: Porebski P]]
 +
[[Category: Pozharski E]]
 +
[[Category: Rupp B]]
 +
[[Category: Stanfield R]]
 +
[[Category: Weichenberger CX]]
 +
[[Category: Wlodawer A]]

Current revision

PHOSPHOLIPASE A2, RE-REFINEMENT OF THE PDB STRUCTURE 1JQ8 WITHOUT THE PUTATIVE COMPLEXED OLIGOPEPTIDE

PDB ID 5vet

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools